Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sotiriou

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Scientific Reports|March 3, 2016
The current use and attitudes towards tumor genome sequencing in breast cancerI Gingras, A Sonnenblick, E de Azambuja, et al.
The Analyst|May 22, 2013
Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embeddingM Verdonck, N Wald, J Janssis, et al.
Leukemia|February 9, 2007
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformationH Akl, B M Badran, N El Zein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2011
Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathologyJohn J Zone, Linda A Schmidt, Ted B Taylor, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
International Journal of Oncology|October 20, 2004
Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancerV Durbecq, C Desmed, M Paesmans, et al.
International Journal of Oncology|December 5, 2003
Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancerF Cardoso, V Durbecq, D Larsimont, et al.
British Journal of Cancer|April 25, 2007
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patientsE de Azambuja, F Cardoso, G de Castro, et al.
Cancer Treatment Reviews|May 20, 2017
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trialsC Solinas, M Ceppi, M Lambertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trialA Di Leo, M Tanner, C Desmedt, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Scientific Reports|March 3, 2016
The current use and attitudes towards tumor genome sequencing in breast cancerI Gingras, A Sonnenblick, E de Azambuja, et al.
The Analyst|May 22, 2013
Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embeddingM Verdonck, N Wald, J Janssis, et al.
Leukemia|February 9, 2007
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transformationH Akl, B M Badran, N El Zein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2011
Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathologyJohn J Zone, Linda A Schmidt, Ted B Taylor, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
International Journal of Oncology|October 20, 2004
Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancerV Durbecq, C Desmed, M Paesmans, et al.
International Journal of Oncology|December 5, 2003
Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancerF Cardoso, V Durbecq, D Larsimont, et al.
British Journal of Cancer|April 25, 2007
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patientsE de Azambuja, F Cardoso, G de Castro, et al.
Cancer Treatment Reviews|May 20, 2017
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trialsC Solinas, M Ceppi, M Lambertini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2007
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trialA Di Leo, M Tanner, C Desmedt, et al.
Pageof 7